The PRYSPRY domain of TRIM5α provides specificity and the capsid recognition motif to retroviral restriction. Restriction of HIV-1 by rhesus TRIM5α (TRIM5αrh) has been correlated to its ability to bind to the HIV-1 core, suggesting that capsid binding is required for restriction. This work explores whether the PRYSPRY domain of TRIM5αrh exhibits an additional function besides binding to the HIV-1 core. Using our recently described structure of the PRYSPRY domain, we performed an exhaustive structure-function study of the surface and interior residues of the PRYSPRY domain. Testing retroviral restriction and capsid binding of an extensive collection of 60 TRIM5αrh PRYSPRY variants revealed that binding is necessary but not sufficient for restriction. In support of this hypothesis, we showed that some human tripartite motif proteins bind the HIV-1 capsid but do not restrict HIV-1 infection, such as human TRIM6 and TRIM34. Overall this work suggested that the PRYSPRY domain serves an unknown function, distinct from the binding of TRIM5αrh to the HIV-1 core, to block HIV-1 infection.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3900861PMC
http://dx.doi.org/10.1016/j.virol.2013.10.012DOI Listing

Publication Analysis

Top Keywords

pryspry domain
24
hiv-1 core
12
rhesus trim5α
8
hiv-1
8
retroviral restriction
8
bind hiv-1
8
capsid binding
8
hiv-1 infection
8
pryspry
7
binding
6

Similar Publications

Redirecting E3 ubiquitin ligases for targeted protein degradation with heterologous recognition domains.

J Biol Chem

December 2024

Department of Pediatrics, Dana Farber/Boston Children's Hospital Cancer and Blood Disorder Center, Boston, Massachusetts, USA; Department of Pediatrics, Harvard Medical School, Boston, Massachusetts, USA; Howard Hughes Medical Institute, Boston Children's Hospital, Boston, Massachusetts, USA. Electronic address:

Targeted protein degradation (TPD) mediated by proteolysis targeting chimeras or molecular glues is an emerging therapeutic strategy. Despite greater than 600 E3 ligases and their associated components, a limited number have been deployed in TPD. Those commonly used include cereblon and von Hippel-Lindau tumor suppressor (VHL), which is expressed widely and for which high affinity ligands are available.

View Article and Find Full Text PDF

Mechanistic Role of TRIM26 in Viral Infection and Host Defense.

Genes (Basel)

November 2024

Shanghai Veterinary Research Institute, Chinese Academy of Agricultural Sciences, 518 Ziyue Road, Shanghai 200241, China.

(TRIM26) is an E3 ubiquitin ligase and a member of the TRIM family. Similar to other TRIM proteins, TRIM26 consists of three domains, collectively termed RBCC: a Really Interesting New Gene (RING) domain, one B-Box domain, and a C terminal domain consisting of a PRY/SPRY domain. The PRY/SPRY domain exhibits relatively higher conservation compared with the RING and B-Box domains, suggesting potentially similar roles across TRIM26 proteins from various species.

View Article and Find Full Text PDF

Identification and characterization of 16 tripartite motif-containing proteins from Takifugu obscurus.

Fish Shellfish Immunol

January 2025

Jiangsu Province Engineering Research Center for Marine Bio-resources Sustainable Utilization, College of Oceanography, Hohai University, Nanjing, 210024, China. Electronic address:

Tripartite motif-containing (TRIM) proteins play important roles in apoptosis, development, autophagy, and innate immunity in vertebrates. In this study, a total of 16 TRIM genes were cloned and identified from obscure puffer Takifugu obscurus. Multiple alignment results showed that most of the deduced ToTRIM proteins contained three typical motifs, a really interesting new gene (RING) zinc-finger domain, one B-box, and a coiled-coil domain, which together formed the TRIM motif found in this large family of proteins.

View Article and Find Full Text PDF
Article Synopsis
  • Pituitary adenomas (PAs) are common brain tumors where the TRIM family, especially TRIM21, is linked to increased cell growth and resistance to therapies, though its specific role in PAs needs further exploration.
  • CRISPR screening and various experiments revealed that TRIM21 enhances cell proliferation and drug resistance in PAs by interacting with ERK1/2, ultimately affecting its activity through ubiquitination.
  • Targeting TRIM21 shows potential benefits in treating PAs, as reducing its levels with drugs like Fimepinostat and Quisinostat could inhibit tumor growth and improve response to existing treatments.
View Article and Find Full Text PDF

NCAPH, ubiquitinated by TRIM21, promotes cell proliferation by inhibiting autophagy of cervical cancer through AKT/mTOR dependent signaling.

Cell Death Dis

August 2024

Department of Pathology, School of Basic Medical Sciences and Qilu Hospital, Shandong University, Jinan, Shandong Province, China.

Article Synopsis
  • Autophagy is a process in our bodies that helps with the growth of cancer, but scientists still need to learn more about how it works in cervical cancer.
  • A protein called NCAPH helps cancer cells grow faster by stopping autophagy from happening, and its behavior is influenced by another protein called TRIM21.
  • TRIM21 makes NCAPH less stable, which leads to less cell growth and affects certain pathways that are important for cancer development, providing new insights for treating cervical cancer.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!